Anti-tumour responses are enhanced by IFN-γ secreted from activated CD8+ T cells through an increase in the expression of MHC class I antigens in tumour cells, thereby making these cancer cells a better target for CD8+ T cells [114]. This evidence concerns the gene IFNG and cancer.